What SEC filings does DENTSPLY SIRONA Inc. submit to the SEC?

DENTSPLY SIRONA Inc. (XRAY) submits several types of SEC filings including Form 4 (insider transactions), Form 144 (proposed insider sales), 8-K reports (material events such as earnings releases, acquisitions, leadership changes), and periodic reports — the 10-Q (quarterly) and 10-K (annual). All filings are publicly available through SEC EDGAR.

What does a Form 4 filing tell me about XRAY?

A Form 4 for XRAY discloses a transaction by a company insider — typically a director, officer, or 10%+ shareholder. It shows the source-reported date, number of shares, price, and updated ownership. These facts do not establish motive or predict future returns.

How do I interpret an 8-K filing from DENTSPLY SIRONA Inc.?

An 8-K signals a material event requiring prompt disclosure. Common triggers include earnings pre-announcements, acquisitions, leadership appointments or departures, credit changes, or regulatory actions. Read the item codes inside the filing to understand exactly what was disclosed before drawing conclusions.

What is the difference between a 10-K and 10-Q for XRAY?

The 10-K is DENTSPLY SIRONA Inc.'s annual report with fully audited financial statements, comprehensive MD&A, and complete risk factor disclosures — filed 60–90 days after fiscal year-end. The 10-Q is a lighter quarterly report with unaudited financials filed for the first three quarters. Together they provide a continuous financial picture of the company.

Where can I see all XRAY SEC filings directly on EDGAR?

You can view all historical DENTSPLY SIRONA Inc. filings on the SEC EDGAR company page for XRAY. Each filing card on this page links directly to the original SEC document.

How often does DENTSPLY SIRONA Inc. file with the SEC?

DENTSPLY SIRONA Inc. files one 10-K per year and up to three 10-Qs per year. Form 4 insider transactions must be reported within two business days of each trade, so the frequency depends on how often insiders are buying or selling XRAY shares. 8-K filings occur whenever a material event happens — which can be several times per quarter for an active company.

XRAY SEC Filing News — DENTSPLY SIRONA Inc.

Latest SEC filings for DENTSPLY SIRONA Inc. (XRAY) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-09.

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and…

Sector: Healthcare Industry: Medical Instruments & Supplies Market Cap: $1.7B CIK: 818479

Total Filings

Bullish Classifications

Bearish Classifications

Insider Transactions

Material Events (8-K)

Periodic Reports

Rule-based classifications for XRAY currently lean bullish. Of the 20 displayed SEC filing records, 5 carry bullish classifications versus 0 bearish classifications. These labels summarize filing attributes; they are not recommendations, probabilities, or evidence of future price direction. There were 15 insider transactions (Form 4) in this period.

XRAY Filing Activity Snapshot 2026-06-05 — 2026-10-09

Insider Transactions (Form 4)

5 buys vs 0 sells

Net insider buying in this period — more purchases than sales reported.

Largest Form 144 Filing

$150.0K

Barber Michael J (Director) · 2026-06-15

15,175 shares · Form 4

Insider Transactions 15 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 15 filings in this group are Form 4s for DENTSPLY SIRONA Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 15 insider filings shown, the breakdown is 9 compensation award, 5 open-market purchase and 1 tax withholding. 5 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Compensation award ×9: Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Open-market purchase ×5: The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.
Tax withholding ×1: Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Form 4 Compensation award Tax / Compensation Filing 2026-10-02

XRAY insider Form 4 filed for equity award, exercise, or tax withholding

MAZELSKY JONATHAN JAY (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award derivative · Phantom Stock (Directors' Deferred Compensation) DDC	3,323	$9.03	$30.0K

Filing: Form 4 (Insider Transaction) Insider: MAZELSKY JONATHAN JAY (Director)

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-08-12

XRAY insider Form 4 filed for equity award, exercise, or tax withholding

Fortson John C. (EVP & CFO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award	24,014	—	—
`A`	Compensation award derivative · Stock Option (Right to Buy)	104,200	—	—

Filing: Form 4 (Insider Transaction) Insider: Fortson John C. (EVP & CFO) Shares: 24,014

View on SEC EDGAR → Open Filing Document →

Form 4 Tax withholding Tax / Compensation Filing 2026-08-11

XRAY insider Form 4 filed for equity award, exercise, or tax withholding

Frohning Andrea L. (SVP, CHRO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`F`	Tax withholding on vested shares	802	$12.12	$9.7K

Filing: Form 4 (Insider Transaction) Insider: Frohning Andrea L. (SVP, CHRO) Shares: 802

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-07-01

XRAY insider Form 4 filed for equity award, exercise, or tax withholding

MAZELSKY JONATHAN JAY (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award derivative · Phantom Stock (Directors' Deferred Compensation) DDC	2,841	$10.56	$30.0K

Filing: Form 4 (Insider Transaction) Insider: MAZELSKY JONATHAN JAY (Director)

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market purchase Insider Buying 2026-06-16

XRAY insider HOSEIN CLYDE (Director) bought 6,500 shares (~$64.9K)

HOSEIN CLYDE, listed as Director at DENTSPLY SIRONA Inc., reported an open-market purchase of 6,500 XRAY shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`P`	Open-market purchase	6,500	$9.98	$64.9K

Filing: Form 4 (Insider Transaction) Insider: HOSEIN CLYDE (Director) Shares: 6,500 Est. Value: $64.9K

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market purchase Insider Buying 2026-06-15

XRAY insider MCKEON BRIAN P (Director) bought 10,000 shares (~$101.2K)

MCKEON BRIAN P, listed as Director at DENTSPLY SIRONA Inc., reported an open-market purchase of 10,000 XRAY shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`P`	Open-market purchase	10,000	$10.12	$101.2K

Filing: Form 4 (Insider Transaction) Insider: MCKEON BRIAN P (Director) Shares: 10,000 Est. Value: $101.2K

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market purchase Insider Buying 2026-06-15

XRAY insider Gladden Brian T (Director) bought 9,985 shares (~$100.0K)

Gladden Brian T, listed as Director at DENTSPLY SIRONA Inc., reported an open-market purchase of 9,985 XRAY shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`P`	Open-market purchase	9,985	$10.02	$100.0K

Filing: Form 4 (Insider Transaction) Insider: Gladden Brian T (Director) Shares: 9,985 Est. Value: $100.0K

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-06-15

XRAY insider Form 4 filed for equity award, exercise, or tax withholding

MAZELSKY JONATHAN JAY (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award	10,000	$10.14	$101.4K

Filing: Form 4 (Insider Transaction) Insider: MAZELSKY JONATHAN JAY (Director) Shares: 10,000

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market purchase Insider Buying 2026-06-15

XRAY insider HOLDEN BETSY D (Director) bought 10,086 shares (~$99.7K)

HOLDEN BETSY D, listed as Director at DENTSPLY SIRONA Inc., reported an open-market purchase of 10,086 XRAY shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`P`	Open-market purchase	10,086	$9.88	$99.7K

Filing: Form 4 (Insider Transaction) Insider: HOLDEN BETSY D (Director) Shares: 10,086 Est. Value: $99.7K

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market purchase Insider Buying 2026-06-15

XRAY insider Barber Michael J (Director) bought 15,175 shares (~$150.0K)

Barber Michael J, listed as Director at DENTSPLY SIRONA Inc., reported an open-market purchase of 15,175 XRAY shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`P`	Open-market purchase	15,175	$9.88	$150.0K

Filing: Form 4 (Insider Transaction) Insider: Barber Michael J (Director) Shares: 15,175 Est. Value: $150.0K

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-06-05

XRAY insider Form 4 filed for equity award, exercise, or tax withholding

LUCIER GREGORY T (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award	38,382	—	—
`G`	Gift	38,382	—	—
`G`	Gift	38,382	—	—
`A`	Compensation award derivative · Stock Option (Right to Buy)	10,900	—	—
`G`	Gift derivative · Stock Option (Right to Buy)	10,900	—	—
`G`	Gift derivative · Stock Option (Right to Buy)	10,900	—	—

Filing: Form 4 (Insider Transaction) Insider: LUCIER GREGORY T (Director) Shares: 115,146

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-06-05

XRAY insider Form 4 filed for equity award, exercise, or tax withholding

Zurbay Donald (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award	22,822	—	—

Filing: Form 4 (Insider Transaction) Insider: Zurbay Donald (Director) Shares: 22,822

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-06-05

XRAY insider Form 4 filed for equity award, exercise, or tax withholding

Vergis Janet S. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award	22,822	—	—

Filing: Form 4 (Insider Transaction) Insider: Vergis Janet S. (Director) Shares: 22,822

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-06-05

XRAY insider Form 4 filed for equity award, exercise, or tax withholding

VARON LESLIE F (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award	22,822	—	—

Filing: Form 4 (Insider Transaction) Insider: VARON LESLIE F (Director) Shares: 22,822

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-06-05

XRAY insider Form 4 filed for equity award, exercise, or tax withholding

MCKEON BRIAN P (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award	28,887	—	—

Filing: Form 4 (Insider Transaction) Insider: MCKEON BRIAN P (Director) Shares: 28,887

View on SEC EDGAR → Open Filing Document →

Material Events 4 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 4 in this period for DENTSPLY SIRONA Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-10-09

XRAY filed 8-K — material company event

DENTSPLY SIRONA Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)

View on SEC EDGAR → Open Filing Document →

Form 8-K/A Amended Material Company Update 2026-08-07

XRAY filed amended 8-K — material company event

DENTSPLY SIRONA Inc. filed an amended 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K/A (Material Event Amendment)

View on SEC EDGAR → Open Filing Document →

Form 8-K Material Company Update 2026-08-06

XRAY filed 8-K — material company event

DENTSPLY SIRONA Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)

View on SEC EDGAR → Open Filing Document →

Form 8-K Material Company Update 2026-06-11

XRAY filed 8-K — material company event

DENTSPLY SIRONA Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)

View on SEC EDGAR → Open Filing Document →

Periodic Reports 1 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 quarterly report (10-Q) for DENTSPLY SIRONA Inc.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-08-06

XRAY filed Quarterly Report (10-Q)

DENTSPLY SIRONA Inc. filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)

View on SEC EDGAR → Open Filing Document →

How we classify DENTSPLY SIRONA Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on XRAY. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — XRAY SEC Filings

More Tools for XRAY

XRAY Full Stock Analysis XRAY Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Semiconductor Demand Zone Tracker Sector Scanner Browse All Stocks

Want deeper XRAY analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the XRAY stock analysis page.

XRAY Full Analysis

Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.

Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer